Investing Profile

Brent Ahrens

VCInvestor

General Partner at Canaan Partners

canaan.com/team/brent-ahrensMenlo Park, California
Photo of Brent Ahrens, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Canaan Partners General Partner
$250K - $20.0M
$10.0M
33
$800M
CompanyStageDateRound SizeTotal Raised
Grey Wolf Therapeutics
Series AFeb 2019£10M
£10M
Unchained Labs
Series CJun 2017$13M
Series AFeb 2015$25M
$38M
Iterum Therapeutics
Series BMay 2017$65M
Series AMar 2016$40M
$105M
Abyrx
Venture RoundDec 2016$10M
$10M
Relievant Medsystems
Series DOct 2016$36M
Series DMar 2012$30M
Series CJul 2009$20M
$156M
Co-investors: Jason Lettmann (Morgenthaler Ventures), Justin Klein (Vensana Capital)
EndoGastric Solutions
Venture RoundDec 2015$50M
Series GMay 2014$30M
Venture RoundJun 2012$13M
Venture RoundApr 2012$2.1M
Series GMar 2012$10.9M
Series FAug 2010$30M
$187.8M
Co-investors: Mike Carusi (ATV Capital)
Minimally invasive devices
Series CNov 2015$14.1M
Debt FinancingJun 2014$6M
Series BJun 2013$2.5M
Series BMar 2013$9M
$31.6M
Co-investors: Wende Hutton (Canaan Partners)
Spinifex Pharmaceuticals
Series CApr 2014$45M
$45M